Revenue: RM12.3 million (up 7.0% from Q3 2023).
Net profit: RM1.5 million (stable with Q3 2023).
Profit margin: 12% (same as Q3 2023).
EPS: RM0.002 (consistent with Q3 2023).
All numbers shown in the chart above are for the trailing 12 month (TTM) period.
Looking ahead, revenues are expected to grow by an average of 12% over the next three years, compared to a growth forecast of 6.2% for the Malaysian healthcare industry.
Malaysian healthcare industry performance.
The company's stock price has fallen 12% from a week ago.
What about risks? Every company has them, and we've spotted 3 warning signs for Metro Healthcare Berhad (of which 1 is a bit concerning!) you should know about.
Do you have feedback on this article? Interested in its content? contact Please contact us directly. Alternatively, email our editorial team at Simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary using only unbiased methodologies, based on historical data and analyst forecasts, and articles are not intended to be financial advice. This is not a recommendation to buy or sell any stock, and does not take into account your objectives or financial situation. We aim to provide long-term, focused analysis based on fundamental data. Note that our analysis may not factor in the latest announcements or qualitative material from price-sensitive companies. Simply Wall St has no position in any stocks mentioned.
